Gender Male
Dr. Chen is a passionate scientist-turned entrepreneur and brings extensive drug discovery experience within multiple blockbuster category drugs. His multidisciplinary training in pharmacology, biochemistry, molecular biology and molecular medicine provides exceptional vision for Aluda.
During his early career in academia in Beijing, Paris and New
York, Dr. Chen worked on novel small molecule anti-cancer drugs and the mammary production of therapeutic proteins. He co-founded Natrogen (acq’d by Takeda) and managed their autoimmune program from discovery to Phase II including a successful Ph 2. At Genentech, Dr. Chen focused on the discovery of therapeutic targets for cancer, and was a key contributor to the understanding of molecular signature of glioblastomas and signaling pathways involved in tumor growth. He designed and executed experiments to analyze the lineage hierarchy of cancer stem cells and to determine the roles of tumor microenvironment and metabolism in tumorogenesis. He produced several high-impact peer-reviewed publications.
Dr. Chen received his B.Sc. N pharmacology from Fudan University, a M.Sc. in biochemistry from Beijing Normal University, and his Ph.D. in Molecular Biology and Genetics from University of Paris. He completed post-doctoral work at Mt. Sinai School of Medicine.
